ArticleCureus2025
Impact of Elevated Low-Density Lipoprotein and the Risk of Acute Coronary Syndrome in Rheumatoid Arthritis: A Retrospective Study.
Article in Cureus, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Objective To analyze the effect of hyperlipidemia on the risk of acute coronary syndrome (ACS) in patients with rheumatoid arthritis (RA). Methods This is a retrospective cohort study from 171 hospitals in the Hospital Corporation of America database, consisting of 1,942 individuals with RA who were retrospectively followed from the year 2020 to 2023. The primary outcome was the incidence of ACS, which included ST elevation myocardial infarction, type 1 non-ST elevation myocardial infarction, and unstable angina. The primary exposure was hyperlipidemia. Odds ratios (ORs) were obtained to ascertain the relationship between ACS (ST elevation myocardial infarction, non-ST elevation myocardial infarction type 1, and unstable angina) and hyperlipidemia (low-density lipoprotein, or LDL > 100 mg/dL). Results A total of 31 patients had the primary outcome of ACS. In addition, 463 patients had the primary exposure of elevated LDL (hyperlipidemia). The risk of physician-diagnosed ACS was significantly greater in participants with RA who additionally had hyperlipidemia when compared to participants who had RA without hyperlipidemia (OR: 3.88; 95% confidence interval (CI): 1.90-7.93, p < 0.01). Conclusion Hyperlipidemia is associated with an increased risk of ACS in patients with RA.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.